Neuraxis
NRXS
6 hedge funds and large institutions have $207K invested in Neuraxis in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
1.09% more ownership
Funds ownership: 0% → 1.09% (+1.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
+$120K |
| 2 |
Stifel Financial
St. Louis,
Missouri
|
+$118K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$7.82K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$4.6K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$258 |
Top Sellers
NRXS Hedge Fund Activity: Q3 2023 in Review
6 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Neuraxis (NRXS) for Q3 2023, worth a combined $207K.
Buyers outnumbered sellers: 6 funds opened new NRXS positions and 0 closed out — a net gain of 6 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Bank of New York Mellon, opening a new position worth an estimated $120K.
- 6 institutional investors held Neuraxis (NRXS) as of Q3 2023, up from 0 in Q2 2023.
- Funds reported $207K of Neuraxis stock for Q3 2023.
- 6 funds opened new Neuraxis positions in Q3 2023 and 0 closed out, a net change of +6 holders.
- The largest Neuraxis buyer in Q3 2023 was Bank of New York Mellon, an estimated $120K added.
Based on aggregated 13F filings for Q3 2023.